BCL2L2 Antikörper (AA 1-100)
Kurzübersicht für BCL2L2 Antikörper (AA 1-100) (ABIN759581)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-100
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Bcl2L2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- Bcl2L2
-
Hintergrund
-
Synonyms: Apoptosis regulator BCL W, Apoptosis regulator Bcl-W, B2CL2_HUMAN, BCL 2 Like 2, Bcl 2 like 2 protein, Bcl 2L2, BCL W, Bcl-2-like protein 2, Bcl2 L2, BCL2 like 2, BCL2 like 2 protein, Bcl2-L-2, Bcl2l2, BCLW.
Background: Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
Gen-ID
- 599
Target
-